Figure 4.

The level of pro-inflammatory eicosanoids (A): [thromboxane B2 (TXB₂) and prostaglandin E2 (PGE₂)] and anti-inflammatory eicosanoids (B): [15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and 12-hydroxyeicosatetraenoic acid (12-HETE)] in the plasma of patients with COVID-19, including those who recovered (n = 66) and those who deceased (n = 22) as well as healthy subjects (n = 33). Data points represent the mean ± SD; a, significantly different from healthy subject, p < 0.05; b, significantly different from patients with COVID-19 recovered, p < 0.05.